The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. This year’s metric has recorded a Price increase of 15.64%. However, over the past six months, we’ve seen a weaker performance of 21.92%. The price of BSX fallen by 13.96% over the last 30 days. And in the last five days, it has surged by 0.10%.
The market performance of Boston Scientific Corp’s stock has been harmonious in recent times. Over the last year, the company’s stock reached its highest point at $107.17 on 02/05/25, while the lowest value for the same duration was $71.88 on 08/05/24.
52-week price history of BSX Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Boston Scientific Corp’s current trading price is -3.62% away from its 52-week high, while its distance from the 52-week low is 43.70%. The stock’s price range during this period has varied between$71.88 and $107.17. The Boston Scientific Corp’s shares, which operate in the Healthcare, saw a trading volume of around 5.27 million for the day, a figure considerably lower than their average daily volume of 8.46 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Boston Scientific Corp (BSX) has experienced a quarterly decline of -1.65% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 152.81B and boasts a workforce of 53000 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 98.67, with a change in price of +12.73. Similarly, Boston Scientific Corp recorded 7,412,522 in trading volume during the last 100 days, posting a change of +14.06%.
BSX’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for BSX stands at 0.53. Similarly, the long-term debt-to-equity ratio is also 0.49.
BSX Stock Stochastic Average
As of today, Boston Scientific Corp’s raw stochastic average for the last 50 days stands at 87.60%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 83.37%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 90.62% and 92.93%, respectively.
